Pulmonary arterial hypertension trials in New Zealand

4 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  Where

  Christchurch, Dunedin

  Age

  18 years and over

  People

  344 worldwide

  Run by

  Insmed Incorporated

  See details and how to joinNCT07179380 · EU 2025-521558-40-00
• Phase 3Taking people
  A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)

  Where

  Auckland, Dunedin, Hamilton

  Age

  18 years to 75 years

  People

  344 worldwide

  Run by

  Insmed Incorporated

  See details and how to joinNCT07481981 · EU 2026-525265-48-00
• Phase 1/2Taking people
  DIAG723 in Adults With Hereditary Hemorrhagic Telangiectasia

  Where

  Grafton

  Age

  18 years and over

  People

  93 worldwide

  Run by

  Diagonal Therapeutics, Inc.

  See details and how to joinNCT07623525
• Phase 3Taking people
  An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

  Where

  Auckland, Christchurch, Hamilton

  Age

  18 years to 75 years

  People

  486 worldwide

  Run by

  Inhibikase Therapeutics

  See details and how to joinNCT07365332 · EU 2024-520218-23-00